Targetable Pathways in the Treatment of Retroperitoneal Liposarcoma is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.581. It has been cited 47 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.581
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →The Ohio State University Wexner Medical Center
Grant: P30 CA016058
National Institutes of Health
Grant: CA210874
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
FWCI
5.60
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals